NWAM LLC’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $538K | Buy |
3,519
+294
| +9% | +$45.1K | 0.03% | 387 |
|
|
2025
Q4 | $471K | Sell |
3,225
-177
| -5% | -$23.2K | 0.03% | 402 |
|
|
2025
Q3 | $445K | Sell |
3,402
-130
| -4% | -$15.9K | 0.02% | 440 |
|
|
2025
Q2 | $408K | Buy |
+3,532
| New | +$398K | 0.02% | 439 |
|
|
2025
Q1 | – | Sell |
-4,255
| Closed | -$414K | – | 573 |
|
|
2024
Q4 | $414K | Buy |
4,255
+186
| +5% | +$19.8K | 0.03% | 415 |
|
|
2024
Q3 | $468K | Buy |
+4,069
| New | +$462K | 0.03% | 397 |
|
|
2024
Q2 | – | Sell |
-3,605
| Closed | -$356K | – | 407 |
|
|
2024
Q1 | $356K | Sell |
3,605
-645
| -15% | -$66.1K | 0.03% | 400 |
|
|
2023
Q4 | $422K | Buy |
4,250
+54
| +1% | +$5.21K | 0.03% | 366 |
|
|
2023
Q3 | $427K | Sell |
4,196
-375
| -8% | -$38.1K | 0.04% | 326 |
|
|
2023
Q2 | $461K | Buy |
4,571
+680
| +17% | +$68K | 0.04% | 342 |
|
|
2023
Q1 | $358K | Sell |
3,891
-571
| -13% | -$49.9K | 0.04% | 332 |
|
|
2022
Q4 | $405K | Buy |
4,462
+847
| +23% | +$71.3K | 0.04% | 351 |
|
|
2022
Q3 | $275K | Sell |
3,615
-1,152
| -24% | -$95.5K | 0.03% | 404 |
|
|
2022
Q2 | $402K | Buy |
4,767
+1,351
| +40% | +$119K | 0.04% | 351 |
|
|
2022
Q1 | $300K | Buy |
3,416
+66
| +2% | +$5.71K | 0.02% | 420 |
|
|
2021
Q4 | $293K | Buy |
3,350
+804
| +32% | +$66.8K | 0.02% | 423 |
|
|
2021
Q3 | $208K | Sell |
2,546
-221
| -8% | -$19.9K | 0.02% | 467 |
|
|
2021
Q2 | $252K | Sell |
2,767
-15
| -0.5% | -$1.34K | 0.02% | 405 |
|
|
2021
Q1 | $238K | Buy |
2,782
+27
| +1% | +$2.42K | 0.02% | 430 |
|
|
2020
Q4 | $260K | Buy |
+2,755
| New | +$241K | 0.03% | 371 |
|
|
2020
Q3 | – | Sell |
-2,763
| Closed | -$241K | – | 371 |
|
|
2020
Q2 | $241K | Buy |
2,763
+181
| +7% | +$15.6K | 0.03% | 355 |
|
|
2020
Q1 | $213 | Sell |
2,582
-939
| -27% | -$83.8K | 0.01% | 349 |
|
|
2019
Q4 | $333K | Sell |
3,521
-380
| -10% | -$34.1K | 0.06% | 284 |
|
|
2019
Q3 | $339K | Buy |
3,901
+661
| +20% | +$59.4K | 0.06% | 261 |
|
|
2019
Q2 | $296K | Sell |
3,240
-803
| -20% | -$68K | 0.06% | 272 |
|
|
2019
Q1 | $348K | Buy |
4,043
+487
| +14% | +$39.1K | 0.08% | 248 |
|
|
2018
Q4 | $273K | Sell |
3,556
-49
| -1% | -$3.81K | 0.07% | 257 |
|
|
2018
Q3 | $278K | Sell |
3,605
-128
| -3% | -$9.46K | 0.06% | 268 |
|
|
2018
Q2 | $253K | Sell |
3,733
-21
| -0.6% | -$1.45K | 0.06% | 281 |
|
|
2018
Q1 | $272K | Sell |
3,754
-5
| -0.1% | -$381 | 0.07% | 259 |
|
|
2017
Q4 | $283K | Sell |
3,759
-1,222
| -25% | -$92.2K | 0.07% | 236 |
|
|
2017
Q3 | $383K | Buy |
4,981
+686
| +16% | +$51.8K | 0.1% | 201 |
|
|
2017
Q2 | $321K | Sell |
4,295
-1,289
| -23% | -$91.4K | 0.06% | 214 |
|
|
2017
Q1 | $372K | Buy |
5,584
+1,450
| +35% | +$96.6K | 0.11% | 189 |
|
|
2016
Q4 | $270K | Buy |
4,134
+145
| +4% | +$9.41K | 0.09% | 220 |
|
|
2016
Q3 | $282K | Buy |
+3,989
| New | +$291K | 0.02% | 203 |
|
Other funds holding NVS
NWAM LLC's NVS Position: Q1 2026 in Review
NWAM LLC increased its Novartis (NVS) stake by 9.1% in Q1 2026, buying an estimated $45.1K and bringing the position to 3,519 shares worth $538K. The position accounts for 0.03% of the portfolio, ranked #387.
NWAM LLC first reported a position in NVS in Q3 2016 and has held it in 36 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- NWAM LLC held 3,519 shares of Novartis worth $538K as of Q1 2026.
- NWAM LLC bought 294 Novartis shares in Q1 2026, an estimated $45.1K.
- Novartis made up 0.03% of NWAM LLC's portfolio in Q1 2026, its #387 holding.
- NWAM LLC first reported a position in Novartis in Q3 2016 and has held it in 36 quarters since.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on NWAM LLC's 13F filing for Q1 2026, filed 4 May 2026.